Plasmodium falciparum merozoite surface antigen, PfRH5, elicits detectable levels of invasion-inhibiting antibodies in humans

Journal of Infectious Diseases

Volumn 208, Issue 10, 2013, Pages 1679-1687

  Patel, Saurabh D ^a,d   Ahouidi, Ambroise D ^a,b,c   Bei, Amy K ^a,b,c   Dieye, Tandakha N ^b,c   Mboup, Souleymane ^b,c   Harrison, Stephen C ^d   Duraisingh, Manoj T ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b Le Dantec Hospital   (United States)

^c UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Invasion; Malaria; Plasmodium falciparum; Recombinant protein expression; RH2; RH5; Vaccine candidate

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; MEROZOITE SURFACE ANTIGEN; PARASITE ANTIGEN; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIGEN RECOGNITION; ANTIPROTOZOAL ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMORAL IMMUNITY; PARASITE ISOLATION; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION;

INVASION; MALARIA; PLASMODIUM FALCIPARUM; RECOMBINANT PROTEIN EXPRESSION; RH2; RH5; VACCINE CANDIDATE;

ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CARRIER PROTEINS; HUMANS; IMMUNOGLOBULIN G; MALARIA, FALCIPARUM; MEROZOITES; PLASMODIUM FALCIPARUM; RECOMBINANT PROTEINS;

EID: 84888604265     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit385     Document Type: Article

References (40)

1. Snow RW, Craig M, Newton CR, Steketee RW. The public health burden of Plasmodium falciparum malaria in Africa: deriving the numbers. Working paper number 11. Bethesda, MD: Fogarty International Center, National Institutes of Health, 2003.
2. Murphy SC, Breman JG. Gaps in the childhood malaria burden in Africa: cerebral malaria, neurological sequelae, anemia, respiratory distress, hypoglycemia, and complications of pregnancy. Am J Trop Med Hyg 2001; 64:57-67.
3. Craig MH, Snow RW, le Sueur D. A climate-based distribution model of malaria transmission in sub-Saharan Africa. Parasitol Today 1999; 15:105-11.
4. Greenwood BM, Bojang K, Whitty CJ, Targett GA. Malaria. Lancet 2005; 365:1487-98.
5. Rayner JC. The merozoite has landed: reticulocyte-binding-like ligands and the specificity of erythrocyte recognition. Trends Parasitol 2009; 25:104-6.
6. Tonkin ML, Roques M, Lamarque MH, et al. Host cell invasion by apicomplexan parasites: insights from the co-structure of AMA1 with a RON2 peptide. Science 2011; 333:463-7.
7. Nair M, Hinds MG, Coley AM, et al. Structure of domain III of the blood-stage malaria vaccine candidate, Plasmodium falciparum apical membrane antigen 1 (AMA1). J Mol Biol 2002; 322:741-53.
8. Tolia NH, Enemark EJ, Sim BK, Joshua-Tor L. Structural basis for the EBA-175 erythrocyte invasion pathway of the malaria parasite Plasmodium falciparum. Cell 2005; 122:183-93.
9. Preiser PR, Khan S, Costa FT, et al. Stage-specific transcription of distinct repertoires of a multigene family during Plasmodium life cycle. Science 2002; 295:342-5.
10. Baum J, Maier AG, Good RT, Simpson KM, Cowman AF. Invasion by P. falciparum merozoites suggests a hierarchy of molecular interactions. PLoS Pathog 2005; 1:e37.
11. Rodriguez M, Lustigman S, Montero E, Oksov Y, Lobo CA. PfRH5: A novel reticulocyte-binding family homolog of Plasmodium falciparum that binds to the erythrocyte, and an investigation of its receptor. PLoS One 2008; 3:e3300.
12. Dvorin JD, Bei AK, Coleman BI, Duraisingh MT. Functional diversification between two related Plasmodium falciparum merozoite invasion ligands is determined by changes in the cytoplasmic domain. Mol Microbiol 2010; 75:990-1006.
13. Baum J, Chen L, Healer J, et al. Reticulocyte-binding protein homologue 5-an essential adhesin involved in invasion of human erythrocytes by Plasmodium falciparum. Int J Parasitol 2009; 39:371-80.
14. Cowman AF, Crabb BS. Invasion of red blood cells by malaria parasites. Cell 2006; 124:755-66.
15. Duraisingh MT, Triglia T, Ralph SA, et al. Phenotypic variation of Plasmodium falciparum merozoite proteins directs receptor targeting for invasion of human erythrocytes. EMBO J 2003; 22:1047-57.
16. Crosnier C, Bustamante LY, Bartholdson SJ, et al. Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum. Nature 2011; 480:534-7.
17. Douglas AD, Williams AR, Illingworth JJ, et al. The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody. Nat Commun 2011; 2:601.
18. Williams AR, Douglas AD, Miura K, et al. Enhancing blockade of Plasmodium falciparum erythrocyte invasion: Assessing combinations of antibodies against PfRH5 and other merozoite antigens. PLoS Pathog 2012; 8:e1002991.
19. Bustamante LY, Bartholdson SJ, Crosnier C, et al. A full-length recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variants. Vaccine 2013; 31:373-9.
20. Anders RF, Crewther PE, Edwards S, et al. Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi. Vaccine 1998; 16:240-7.
21. Cohen S. Progress in malaria vaccine development. Br Med Bull 1982; 38:161-5.
22. Asante KP, Abdulla S, Agnandji S, et al. Safety and efficacy of the RTS, S/AS01E candidate malaria vaccine given with expanded-programmeon- immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial. Lancet Infect Dis 2011; 11:741-9.
23. Duncan CJ, Hill AV. What is the efficacy of the RTS, S malaria vaccine? BMJ 2011; 343:d7728.
24. Crabb BS, Beeson JG. Promising functional readouts of immunity in a blood-stage malaria vaccine trial. PLoS Med 2005; 2:e380.
25. Richards JS, Beeson JG. The future for blood-stage vaccines against malaria. Immunol Cell Biol 2009; 87:377-90.
26. Spring MD, Cummings JF, Ockenhouse CF, et al. Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A. PLoS One 2009; 4: e5254.
27. Genton B, Betuela I, Felger I, et al. A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. J Infect Dis 2002; 185:820-7.
28. Lopaticki S, Maier AG, Thompson J, et al. Reticulocyte and erythrocyte binding-like proteins function cooperatively in invasion of human erythrocytes by malaria parasites. Infect Immun 2011; 79:1107-17.
29. Tessier DC, Thomas DY, Khouri HE, Laliberte F, Vernet T. Enhanced secretion from insect cells of a foreign protein fused to the honeybee melittin signal peptide. Gene 1991; 98:177-83.
30. Schmidt TG, Skerra A. The random peptide library-assisted engineering of a C-terminal affinity peptide, useful for the detection and purification of a functional Ig Fv fragment. Protein Eng 1993; 6:109-22.
31. Egan AF, Burghaus P, Druilhe P, Holder AA, Riley EM. Human antibodies to the 19 kDa C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 inhibit parasite growth in vitro. Parasite Immunol 1999; 21:133-9.
32. Bei AK, Desimone TM, Badiane AS, et al. A flow cytometry-based assay for measuring invasion of red blood cells by Plasmodium falciparum. Am J Hematol 2010; 85:234-7.
33. Chotivanich K, Udomsangpetch R, Simpson JA, et al. Parasite multiplication potential and the severity of falciparum malaria. J Infect Dis 2000; 181:1206-9.
34. Sahar T, Reddy KS, Bharadwaj M, et al. Plasmodium falciparum reticulocyte binding-like homologue protein 2 (PfRH2) is a key adhesive molecule involved in erythrocyte invasion. PLoS One 2011; 6: e17102.
35. Reiling L, Richards JS, Fowkes FJ, et al. Evidence that the erythrocyte invasion ligand PfRh2 is a target of protective immunity against Plasmodium falciparum malaria. J Immunol 2010; 185:6157-67.
36. Okech BA, Corran PH, Todd J, et al. Fine specificity of serum antibodies to Plasmodium falciparum merozoite surface protein, PfMSP-1(19), predicts protection from malaria infection and high-density parasitemia. Infect Immun 2004; 72:1557-67.
37. Corran PH, O'Donnell RA, Todd J, et al. The fine specificity, but not the invasion inhibitory activity, of 19-kilodalton merozoite surface protein 1-specific antibodies is associated with resistance to malarial parasitemia in a cross-sectional survey in The Gambia. Infect Immun 2004; 72:6185-9.
38. Triglia T, Duraisingh MT, Good RT, Cowman AF. Reticulocyte-binding protein homologue 1 is required for sialic acid-dependent invasion into human erythrocytes by Plasmodium falciparum. Mol Microbiol 2005; 55:162-74.
39. Bushkin GG, Ratner DM, Cui J, et al. Suggestive evidence for Darwinian selection against asparagine-linked glycans of Plasmodium falciparum and Toxoplasma gondii. Eukaryot Cell 2010; 9:228-41.
40. Chen L, Lopaticki S, Riglar DT, et al. An EGF-like protein forms a complex with PfRh5 and is required for invasion of human erythrocytes by Plasmodium falciparum. PLoS Pathog 2011; 7:e1002199.